Number of patients achieving a complete response (CR) 24 months [clinicaltrials_resource:eb0100a06958e38092f1ce851da8c8fc]
Complete Response is defined as patients that stop intensive deferasirox -DFO treatment, at any time point during the 24 months of study, based on an improvement in the cardiac MRI T2* value being >10ms, and continue to be treated with deferasirox monotherapy without any further need for reverting back to intensive iron chelation treatment during the 24 months of study.
clinicaltrials_vocabulary:secondary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:secondary-outcome]
Number of patients achieving a complete response (CR) 24 months [clinicaltrials_resource:eb0100a06958e38092f1ce851da8c8fc]
Complete Response is defined as patients that stop intensive deferasirox -DFO treatment, at any time point during the 24 months of study, based on an improvement in the cardiac MRI T2* value being >10ms, and continue to be treated with deferasirox monotherapy without any further need for reverting back to intensive iron chelation treatment during the 24 months of study.
Bio2RDF identifier
eb0100a06958e38092f1ce851da8c8fc
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:eb0100a06958e38092f1ce851da8c8fc
measure [clinicaltrials_vocabulary:measure]
Number of patients achieving a complete response (CR)
time frame [clinicaltrials_vocabulary:time-frame]
description
Complete Response is defined a ...... during the 24 months of study.
identifier
clinicaltrials_resource:eb0100a06958e38092f1ce851da8c8fc
title
Number of patients achieving a complete response (CR) 24 months
@en
type
label
Number of patients achieving a ...... 100a06958e38092f1ce851da8c8fc]
@en